Healthcare provider profile · identity verified

Vincent M Rizzo, MD

Family Practice · KENOSHA, WI · NPI 1205943552

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	730	175
Amlodipine Besylate	Amlodipine Besylate	377	97
Lisinopril	Lisinopril	259	67
Levothyroxine Sodium	Levothyroxine Sodium	244	54
Pantoprazole Sodium	Pantoprazole Sodium	213	51
Losartan Potassium	Losartan Potassium	208	54
Metformin Hcl	Metformin Hcl	204	56
Omeprazole	Omeprazole	167	43
Alprazolam	Alprazolam	153	30
Metoprolol Succinate	Metoprolol Succinate	147	31
Tamsulosin Hcl	Tamsulosin Hcl	143	34
Sertraline Hcl	Sertraline Hcl	139	27
Simvastatin	Simvastatin	129	38
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	125	31
Pravastatin Sodium	Pravastatin Sodium	124	29
Alendronate Sodium	Alendronate Sodium	122	36
Allopurinol	Allopurinol	99	24
Hydrochlorothiazide	Hydrochlorothiazide	91	29
Furosemide	Furosemide	89	22
Zolpidem Tartrate	Zolpidem Tartrate	85	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	84	21
Meloxicam	Meloxicam	83	17
Metformin Hcl Er	Metformin Hcl	83	19
Gabapentin	Gabapentin	77	15
Metoprolol Tartrate	Metoprolol Tartrate	69	17
Albuterol Sulfate Hfa	Albuterol Sulfate	58	23
Potassium Chloride	Potassium Chloride	58	15
Rosuvastatin Calcium	Rosuvastatin Calcium	58	26
Escitalopram Oxalate	Escitalopram Oxalate	56	13
Benazepril Hcl	Benazepril Hcl	54	12
Pioglitazone Hcl	Pioglitazone Hcl	53	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	52	11
Atenolol	Atenolol	49	11
Oxybutynin Chloride Er	Oxybutynin Chloride	49	suppressed
Glipizide	Glipizide	48	13
Ezetimibe	Ezetimibe	47	11
Clopidogrel	Clopidogrel Bisulfate	46	13
Lovastatin	Lovastatin	42	suppressed
Januvia	Sitagliptin Phosphate	41	suppressed
Montelukast Sodium	Montelukast Sodium	38	suppressed
Carvedilol	Carvedilol	36	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	36	16
Azithromycin	Azithromycin	35	29
Eliquis	Apixaban	35	suppressed
Xarelto	Rivaroxaban	35	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	11
Ropinirole Hcl	Ropinirole Hcl	34	suppressed
Famotidine	Famotidine	33	suppressed
Ozempic	Semaglutide	33	suppressed
Synthroid	Levothyroxine Sodium	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Enalapril Maleate	Enalapril Maleate	30	suppressed
Trazodone Hcl	Trazodone Hcl	30	suppressed
Bupropion Hcl Sr	Bupropion Hcl	29	suppressed
Finasteride	Finasteride	29	suppressed
Spironolactone	Spironolactone	29	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Fenofibrate	Fenofibrate	28	suppressed
Ibuprofen	Ibuprofen	28	suppressed
Naproxen	Naproxen	27	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	26	suppressed
Lansoprazole	Lansoprazole	26	suppressed
Tramadol Hcl	Tramadol Hcl	26	suppressed
Fluticasone Propionate	Fluticasone Propionate	25	suppressed
Trulicity	Dulaglutide	25	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	22	13
Nystatin	Nystatin	22	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Jardiance	Empagliflozin	21	suppressed
Tresiba Flextouch U-100	Insulin Degludec	21	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	suppressed
Prednisone	Prednisone	20	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	17
Clonazepam	Clonazepam	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Amoxicillin	Amoxicillin	18	11
Doxycycline Hyclate	Doxycycline Hyclate	18	14
Glipizide Er	Glipizide	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Midodrine Hcl	Midodrine Hcl	18	suppressed
Myrbetriq	Mirabegron	18	suppressed
Eszopiclone	Eszopiclone	17	suppressed
Glyburide-Metformin Hcl	Glyburide/Metformin Hcl	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Celecoxib	Celecoxib	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Baclofen	Baclofen	15	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Lorazepam	Lorazepam	15	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	11
Comfort Ez Pen Needle	Pen Needle, Diabetic	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Cefdinir	Cefdinir	13	12
Dutasteride	Dutasteride	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Fenofibrate	Fenofibrate,micronized	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Methylprednisolone	Methylprednisolone	13	13
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Bydureon Bcise	Exenatide Microspheres	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	11	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error